ANAB
AnaptysBio Inc

2,054
Mkt Cap
$1.27B
Volume
378,661.00
52W High
$47.86
52W Low
$12.21
PE Ratio
-15.94
ANAB Fundamentals
Price
$44.94
Prev Close
$45.78
Open
$45.80
50D MA
$37.01
Beta
0.68
Avg. Volume
757,700.00
EPS (Annual)
-$5.12
P/B
-42.13
Rev/Employee
$671,176.47
Loading...
Loading...
News
all
press releases
Camber Capital Management LP Sells 625,000 Shares of AnaptysBio, Inc. $ANAB
Camber Capital Management LP decreased its position in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 83.3% during the 2nd quarter, according to its most recent filing with the SEC. The...
MarketBeat·22h ago
News Placeholder
More News
News Placeholder
Stifel Nicolaus Lowers AnaptysBio (NASDAQ:ANAB) Price Target to $56.00
Stifel Nicolaus reduced their price target on shares of AnaptysBio from $80.00 to $56.00 and set a "buy" rating on the stock in a research note on Thursday...
MarketBeat·2d ago
News Placeholder
AnaptysBio (NASDAQ:ANAB) Hits New 1-Year High - Still a Buy?
AnaptysBio (NASDAQ:ANAB) Sets New 52-Week High - Still a Buy...
MarketBeat·4d ago
News Placeholder
AnaptysBio (NASDAQ:ANAB) Reaches New 1-Year High - Here's Why
AnaptysBio (NASDAQ:ANAB) Reaches New 1-Year High - Still a Buy...
MarketBeat·8d ago
News Placeholder
30,642 Shares in AnaptysBio, Inc. $ANAB Bought by XTX Topco Ltd
XTX Topco Ltd acquired a new stake in shares of AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and...
MarketBeat·9d ago
News Placeholder
Geode Capital Management LLC Sells 27,809 Shares of AnaptysBio, Inc. $ANAB
Geode Capital Management LLC trimmed its stake in AnaptysBio, Inc. (NASDAQ:ANAB - Free Report) by 5.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange...
MarketBeat·9d ago
News Placeholder
AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Moderate Buy" by Analysts
AnaptysBio, Inc. (NASDAQ:ANAB - Get Free Report) has been given an average recommendation of "Moderate Buy" by the thirteen ratings firms that are currently covering the company, Marketbeat reports...
MarketBeat·16d ago
News Placeholder
AnaptysBio (NASDAQ:ANAB) Sets New 52-Week High - Here's What Happened
AnaptysBio (NASDAQ:ANAB) Sets New 52-Week High - Here's What Happened...
MarketBeat·18d ago
News Placeholder
Share Buyback Program Declared by AnaptysBio (NASDAQ:ANAB) Board of Directors
AnaptysBio (NASDAQ:ANAB - Get Free Report) announced that its Board of Directors has approved a share buyback plan on Friday, November 21st, RTT News reports. The company plans to buyback $100.00...
MarketBeat·20d ago
News Placeholder
AnaptysBio (NASDAQ:ANAB) Shares Gap Down - Time to Sell?
AnaptysBio (NASDAQ:ANAB) Shares Gap Down - Here's Why...
MarketBeat·21d ago

Latest ANAB News

View

Advertisement|Remove ads.

Advertisement|Remove ads.